IRCT20190817044550N4已完成Unknown
Comparison of Deferazirox and Deferoxamine on Serum Ferritin Levels Changes in Major Beta Thalassemia Patients
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 no limit（—）
- 性别
- All
入选标准
- •The age of the patients was 2 years and older
- •Have a normal serum creatinine level
- •Absence of proteinuria in U/A patients
- •The serum ferritin levels of the patients should be above 1000 mg/dl, or the patients should have had more than 10 blood transfusions, or the volume of blood transferred should be more than 100 cc/kg
排除标准
- •Pregnancy and breastfeeding
- •Resistant levels greater than 5 times the normal value of liver transaminase
- •Severe nausea and vomiting in the patient
- •Patient refusal to participate in the study
研究者
相似试验
招募中
不适用
Efficay comparison two oral chelators combination in patients with beta-thalassemiaIRCT20160310026998N7Tabriz University of Medical Sciences54
尚未招募
2 期
Efficacy and safety of triple iron chelator (deferoxamine, deferasirox, and deferiprone) versus dual iron chelator (deferoxamine and deferasirox) combination therapy for reducing iron overload in transfusion-dependent beta-thalassaemia with very high iron overload.ThalassaemiaSLCTR/2023/010Prof Anuja Premawardhena
已完成
2 期
Effect of Osveral on iron overload in beta thalassemia major patients.beta thalassemia.beta thalassemiaIRCT2015102524679N2Investigator69
已完成
不适用
?Exir research project of desferoxamin with brand name of Deferoxirthalassemia major.Cooley anaemia Severe beta thalassaemia Thalassaemia: intermedia majorIRCT2015012620818N1exir pharmacutical company100
已完成
不适用
Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron OverloadPateints of β-thalassemia Major With Iron OverloadNCT06468423RESnTEC, Institute of Research142